NEW YORK (Reuters Health) – In nondiabetics, high glucose levels signal an increased risk for contrast-induced acute kidney injury during coronary angiography, new research suggests. “Although diabetes is…
NEW YORK (Reuters Health) – Most women with gestational diabetes do not require insulin while they’re giving birth, Spanish researchers report in the American Journal of Obstetrics and…
NEW YORK (Reuters Health) – Sequential screening for type 2 diabetes is cost effective when started between the ages of 30 and 45 years and repeated every 3…
NEW YORK (Reuters Health) – Once-a-week treatment with long-acting exenatide (Byetta) produces sustained glycemic control and weight loss in diabetics, a multicenter trial has shown. “This study confirms…
NEW YORK (Reuters Health) – In diabetics with heart failure, use of metformin is associated with a lower risk of mortality than use of other anti-diabetic agents, even…
NEW YORK (Reuters Health) – In young children with type 1 diabetes, early treatment with an insulin pump — preferably starting at diagnosis — improves metabolic control, new…
NEW YORK (Reuters Health) – Rosuvastatin is safe and effective in children with familial hypercholesterolemia, although many will not achieve consensus targets for low density lipoprotein (LDL) cholesterol,…
Program Overview The Best Practice Series in Atherosclerosis is a series of 5-minute videos featuring top physicians discussing the best ways to diagnose and treat atherosclerosis based on…
Program Overview The Best Practice Series in Atherosclerosis is a series of 5-minute videos featuring top physicians discussing the best ways to diagnose and treat atherosclerosis based on…
NEW YORK (Reuters Health) – A normal coronary artery calcium (CAC) scan in middle-age appears to have a “warranty period” of about four years, during which the patient…